课题基金 / 基金详情

Randomized Double-Blind Placebo-Controlled Clinical Trial to Assess the Efficacy of Mycophenolate Mofetil in Subclinical Interstitial Lung Disease Associated with Systemic Sclerosis: a Feasibility Study

Randomized Double-Blind Placebo-Controlled Clinical Trial to Assess the Efficacy of Mycophenolate Mofetil in Subclinical Interstitial Lung Disease Associated with Systemic Sclerosis: a Feasibility Study
评估吗替麦考酚酯治疗与系统性硬化症相关的亚临床间质性肺病疗效的随机双盲安慰剂对照临床试验：一项可行性研究
批准号：
463257
负责人：
Hoa Sabrina A
金额：
$25.25万
依托单位：
Centre hospitalier de l'Universit de Montral (CHUM)
依托单位国家：
加拿大
项目类别：
Operating Grants
财政年份：
2022
资助国家：
加拿大
项目状态：
未结题
起止时间：
2022-03-01 至 2025-12-01
来源：
https://webapps.cihr-irsc.gc.ca/decisions/p/project_details.html?applId=463257&lang=en
关键词：
Immunosuppressive Drugs Interstitial Lung Disease Systemic Sclerosis (Scleroderma)

项目摘要

项目成果

Hoa Sabrina A的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Scleroderma (or systemic sclerosis) is a rare but life-threatening disease in which the immune system attacks its own tissues, leading to excessive scarring (fibrosis) of the skin and internal organs. Scleroderma affects over 10,000 individuals in Canada
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Immunosuppressive treatment for interstitial lung disease in systemic sclerosis: effectiveness in mild and late clinical subtypes
  • 批准号：
    367130
  • 项目类别：
    Studentship Programs
  • 资助金额：
    $1.27万
  • 财政年份：
    2016
  • 负责人：
    Hoa Sabrina A
  • 依托单位：
    McGill University
海外基金